Advertisement

Responses to Epstein-Barr Virus in Immune Deficient Patients

  • Shinji Harada
  • Eiji Tatsumi
  • Helen Lipscomb
  • David T. Purtilo

Abstract

Two decades have passed since Epstein-Barr virus (EBV) was described (1) and yet new diseases continue to be attributed to the virus. Debates initiated in the early 1960’s are ongoing regarding the role of the virus in Burkitt lymphoma (BL), and nasopharyngeal carcinoma (NPC). Recently, the opportunistic malignant lymphomas (ML) occurring in immune deficient individuals have provided new puzzles. Questions remaining to be answered are whether latent virus is activated in B cells transformed by other agents or alternatively, does the virus infect the malignant B cell after transformation owing to the presence of viral receptors on the cell. Attention has also been directed to find oncogenic and benign strains of the virus. In our view, underlying inherited or environmentally induced immune deficiency is important in determining the outcome of EBV infections.

Keywords

Immune Deficiency Natural Killer Cell Activity Burkitt Lymphoma Infectious Mononucleosis Primary Immunodeficiency Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Epstein, M.A., Achong, B.G., and Barr, Y.M. Virus particles in cultured lymphoblasts from Burkitt’s Lymphoma. Lancet, i:702–703, 1964.CrossRefGoogle Scholar
  2. 2.
    Purtilo, D.T. X-linked lymphoproliferative syndrome: an immunodeficiency disorder with acquired agammaglobulinemia, fatal infectious mononucleosis or malignant lymphoma. Arch. Path. Lab. Med., 106:119, 1981.Google Scholar
  3. 3.
    Henle, W., Henle, G., and Lennette, E.T. Epstein-Barr virus. Sci. Am., 241:48, 1979.PubMedCrossRefGoogle Scholar
  4. 4.
    Niederman, J.C. Prevalence, incidence and persistence of EB virus antibody in young adults. N. Engl. J. Med., 282:361, 1970.PubMedCrossRefGoogle Scholar
  5. 5.
    Tosato, G., Magrath, I., Koski, I., Dooley, N., and Blaese, M. Activation of suppressor T cells during Epstein-Barr-virus-induced infectious mononucleosis. N. Engl. J. Med., 301:1133, 1979.CrossRefGoogle Scholar
  6. 6.
    Klein, G., Svedmyr, E., Jondal, M., and Persson, P.O. EBV-determined nuclear antigen (EBNA)-positive cells in the peripheral blood of infectious mononucleosis patients. Int. J. Cancer, 17:21, 1976.PubMedCrossRefGoogle Scholar
  7. 7.
    Robinson, J.E., Smith, D., and Niederman, J. Plasmacytic differentiation of circulating Epstein-Barr virus-infected B lymphocytes during acute infectious mononucleosis. J. Exp. Med., 153:235, 1980.CrossRefGoogle Scholar
  8. 8.
    Epstein-Barr Virus. Editors, M.A. Epstein and B. Achong, Springer-Verlag, Berlin, 1979.Google Scholar
  9. 9.
    Purtilo, D.T. Immunopathology of infectious mononucleosis and other complications of Epstein-Barr virus infections. In: S.C. Sommers and P.P. Rosen (eds.), Pathology Annual, 1980. pp. 253–299. New York: Appleton-Century-Crofts, 1980.Google Scholar
  10. 10.
    Purtilo, D.T., DeFlorio, D., Hutt, L.M., Bhawan, J., Yang, J.P.S., Otto, R., and Edwards, W. Variable phenotypic expression of an X-linked recessive lymphoproliferative syndrome. N. Engl. J. Med., 297:1077, 1977.PubMedCrossRefGoogle Scholar
  11. 11.
    Purtilo, D.T., Paquin, L.A., DeFlorio, D., Virzi, F., and Sukhuja, R. Immunodiagnosis and immunopathogenesis of the X-linked recessive lymphoproliferative syndrome. Sem. Hematol. 16:309, 1979.Google Scholar
  12. 12.
    Purtilo, D.T. Hypothesis: pathogenesis and phenotypes of an X-linked recessive lymphoproliferative syndrome. Lancet, ii:882, 1976.CrossRefGoogle Scholar
  13. 13.
    Purtilo, D.T., Sakamoto, K., Barnabei, V., Seeley, J., Bechtold, T., Rogers, G., Yetz, J., and Harada, S. Epstein-Barr virus-induced diseases in males with the X-linked lymphoproliferative syndrome (XLP). Am. J. Med., 73: 49, 1982.PubMedCrossRefGoogle Scholar
  14. 14.
    Purtilo, D.T., Sakamoto, K., Saemundsen, A.K., Sullivan, J.L., Synnerholm, A.C., Andersson-Anvret, M., Pritchard, J., Sloper, C., Sieff, Collins, R., Barnes, N., Knight, J., Sandstedt, B., and Klein, G. Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative disease by clinical, virological and immunopathological studies. Cancer Res., 41:4226, 1981.PubMedGoogle Scholar
  15. 15.
    Saemundsen, A.K., Purtilo, D.T., Sakamoto, K., Sullivan, J.L., Synnerholm, A.C., Hanto, D., Simmons, R., Anvret, M., Collins, R., and Klein, G. Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization. Cancer Res., 41:4237, 1981.PubMedGoogle Scholar
  16. 16.
    Seeley, J.K., Sakamoto, K., Ip, S., Hansen, P., and Purtilo, D.T. Abnormal subsets in the X-linked lymphoproliferative syndrome. J. Immunol., 127:2618, 1981.PubMedGoogle Scholar
  17. 17.
    Purtilo, D.T., Yang, J.P.S., Cassel, C.K., Harper, P., Stephenson, S.R., Landing, B.H. and Vawter, G.F. X-linked recessive progressive combined variable immunodeficiency (Duncan’s disease). Lancet, i: 935, 1975.CrossRefGoogle Scholar
  18. 18.
    Lindsten, T., Seeley, J.K., Sakamoto, K., Yetz, J., Harada, S., Bechtold, T., Rogers, G., and Purtilo, D.T. Immune deficiency in the X-linked lymphoproliferative syndrome. II. Immunoregulatory T cell defects. J. Immunol., 129:2536, 1982.PubMedGoogle Scholar
  19. 19.
    Ochs, H.D., Sullivan, J.L., Wedgewood, R.J., Seeley, J.K., Sakamoto, K., and Purtilo, D.T. X-linked lymphoprolifer-ative syndrome: abnormal antibody responses to bacteriophage ØX174. In: R. Wedgewood and F. Rosen (eds.), Primary Immunodeficiency Diseases. New York: Alan R Liss, 1983.Google Scholar
  20. 20.
    Seeley, J.K., Harada, S., Bechtold, T., Ochs, H.D., Wedgewood, R.J., Sakamoto, K., Lindsten, T., Yetz, J., and Purtilo, D.T. Primary and acquired immune defects in X-linked lymphoproliferative syndrome. In preparation.Google Scholar
  21. 21.
    Harada, S., Bechtold, T., and Purtilo, D.T. Comparison of long-term T-cell-mediated immunity to Epstein-Barr virus and NK cell-activity in obligate carrier females and males with the X-linked lymphoproliferative syndrome. Int. J. Cancer, 216:739, 1982.CrossRefGoogle Scholar
  22. 22.
    Szigeti, R., Masucci, M.G., Henle, W., Henle, G, Purtilo, D.T., and Klein, G. Effects of different EBV-determined antigens (EBNA, EA and VCA) on mononucleosis and certain immunodeficiencies. Clin. Immunol. Immunopath., 22:128, 1982.CrossRefGoogle Scholar
  23. 23.
    Sullivan, J.L., Byron, K., Brewster, F., and Purtilo, D.T. Deficient natural killer cell activity in the X-linked lymphoproliferative syndrome. Science, 210:543, 1981.CrossRefGoogle Scholar
  24. 24.
    Purtilo, D.T. Immune deficiency predisposing to Epstein-Barr virus-induced lymphoproliferative diseases: the X-linked lymphoproliferative syndrome as a model. In: G. Klein and S. Weinhouse (eds.), Advances in Cancer Research. Vol. 34, pp. 279–312. New York: Academic Press, 1980.Google Scholar
  25. 25.
    Sakamoto, K., Freed, H., and Purtilo, D.T. Antibody re sponses to Epstein-Barr virus in families with the X-linked lymphoproliferative syndrome. J. Immunol., 125:921, 1980.PubMedGoogle Scholar
  26. 26.
    Sakamoto, K., Seeley, J.K., Lindsten, T., Sexton, J., Yetz, J., Ballow, M., and Purtilo, D.T. Abnormal anti-Epstein-Barr virus antibodies in carriers of the X-linked lymphoproliferative syndrome and in females at risk. J. Immunol., 128:904, 1982.PubMedGoogle Scholar
  27. 27.
    Seeley, J.K., Bechtold, T., Lindsten, T., and Purtilo, D.T. NK deficiency in X-linked lymphoproliferative syndrome. In: R.B. Herberman (ed.), Natural Cell Mediated Immunity 1982. Vol. 2, pp. 1211–1218. New York: Academic Press, 1982.Google Scholar
  28. 28.
    Rickinson, A.B., Moss, D.J., Wallace, L.E., Rowe, M., Misko, I.S., Epstein, M.A., and Pope, J.H. Long-term T-cell-mediated immunity to Epstein-Barr virus. Cancer Res., 41:4216, 1981.PubMedGoogle Scholar
  29. 29.
    Purtilo, D.T. and Sullivan, J.L. Immunological bases for superior survival of females. Am. J. Dis. Child., 133:1251, 1979.PubMedGoogle Scholar
  30. 30.
    Klein, G. Lymphoma development in mice and humans: diversity of initiation is followed by convergent cytogenetic evolution. Proc. Natl. Acad. Sci., 76: 2442, 1979.PubMedCrossRefGoogle Scholar
  31. 31.
    Rowley, J.D. Identification of the constant chromosome regions involved in human hematologic malignant disease. Science, 216: 794, 1982.CrossRefGoogle Scholar
  32. 32.
    Kersey, J.H. and Spector, B.D. Immune deficiency disease. In: J. F. Fraumeni, Jr. (ed.), Persons at High Risk of Cancer: An Approach to Cancer Etiology and Control, pp. 55–67. New York: Academic Press, 1975.Google Scholar
  33. 33.
    Saemundsen, A.K. Epstein-Barr virus-carrying lymphoma in a patient with ataxia-telangiectasia. Brit. Med. J., 282:425, 1981.CrossRefGoogle Scholar
  34. 34.
    Purtilo, D.T., Liao, S.A., Sakamoto, K., Snyder, L.M., DeFlorio, D., Bhawan, J., Paquin, L.A., Yang, J.P.S., Hutt-Fletcher, L.M., Muralidharan, K., Raffa, P., Saemundsen, A.K., and Klein, G. Diverse familial malignant tumors and Epstein-Barr virus. Cancer Res., 41:4248, 1981.PubMedGoogle Scholar
  35. 35.
    Penn, I. Depressed immunity and the development of cancer. Clin. Exp. Immunol., 46:459–474, 1981.PubMedGoogle Scholar
  36. 36.
    Hanto, D.W., Frizzera, G., Purtilo, D.T., Sakamoto, K., Sullivan, J.L., Saemundsen, A.K., Klein, G., Simmons, R.L., and Najarian, J.S. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res., 41:4253, 1981.PubMedGoogle Scholar
  37. 37.
    Hanto, D.W., Frizzera, G., Gajl-Peczalska, K.J., Sakamoto, K., Purtilo, D.T., Balfour, H.H., Simmons, R.L., and Najarian, J.S. Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: Acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N. Engl. J. Med., 306:913, 1982.PubMedCrossRefGoogle Scholar
  38. 38.
    Bieber, C. Lymphoma in cardiac transplant recipients associated with cyclosporin A, prednisone, and anti-thymocyte globulin (ATG). In: D.T. Purtilo (ed.), Immune Deficiency and Cancer: Epstein-Barr Virus and Lymphoproliferative Malignancies. New York: Plenum Press, in press.Google Scholar
  39. 39.
    Reece, E.R., Gartner, J.G., Seemayer, T.A., Joncas, J.H. and Pagano, J.S. Epstein-Barr virus in a malignant lympho-proliferative disorder of B cells occurring after thymic epithelial transplantation for combined immunodeficiency. Cancer Res., 41:4243, 1981.PubMedGoogle Scholar
  40. 40.
    Schubach, W.H., Hackman, R., Neiman, P.E., Miller, G., Thomas, E.D. Blood, in press.Google Scholar
  41. 41.
    Fox, R., McMillan, R., Spruce, W., Tani, P., and Mason, D. Analysis of T lymphocytes after bone marrow transplantation using monoclonal antibodies. Blood, 60:578, 1982.PubMedGoogle Scholar
  42. 42.
    Look, A.T., Naegle, R.F., Calihan, T., Herrod, H.G., and Henle, W. Fatal Epstein-Barr virus infection in a child with acute lymphoblastic leukemia in remission. Cancer Res., 41:4280, 1981.PubMedGoogle Scholar
  43. 43.
    Hardy, C., Harada, S., Lubin, B., Sanger, W., von Schmidt, B., Yetz, J., Saemundsen, A.K., Feusner, J., Lennette, E., Linder, J., Seeley, J.K., and Purtilo, D.T. Epstein-Barr virus (EBV) induced lymphoproliferation complicating acute lymphoblastic leukemia. J. Peds., in press.Google Scholar
  44. 44.
    Sonnabend, J., Witkin, S.S., and Purtilo, D.T. Acquired immunodeficiency syndrome (AIDS), opportunistic infections and malignancies in male homosexuals. A hypothesis of etiologic factors in pathogenesis. J. Am. Med. Assoc, 249:2370, 1983.CrossRefGoogle Scholar
  45. 45.
    Zeigler, J.L., Wagner, G., and Greenspan, J.S. Diffuse, Undifferentiated, non-Hodgkin’s lymphoma in homosexual male — United States. Morbidity and Mortality Weekly Report, 31:277, 1982.Google Scholar

Copyright information

© Plenum Publishing Corporation 1984

Authors and Affiliations

  • Shinji Harada
    • 1
  • Eiji Tatsumi
    • 1
  • Helen Lipscomb
    • 1
  • David T. Purtilo
    • 1
  1. 1.Department of Pathology & Laboratory MedicineUniversity of Nebraska Medical CenterOmahaUSA

Personalised recommendations